Breed's Hill Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$209K Buy
+3,000
New +$171K 0.1% 132
2025
Q1
Sell
-3,000
Closed -$210K 137
2024
Q4
$210K Buy
+3,000
New +$249K 0.11% 126

Other funds holding ACLS

Breed's Hill Capital's ACLS Position: Q2 2025 in Review

Breed's Hill Capital opened a new position in Axcelis (ACLS) in Q2 2025: 3,000 shares worth $209K. The stake represents 0.1% of the portfolio and ranks #132 among its holdings. This is a return to the name: Breed's Hill Capital previously reported a position in ACLS as recently as Q4 2024.

Breed's Hill Capital first reported a position in ACLS in Q4 2024 and has held it in 2 quarters since. The position peaked at $210K in Q4 2024. 328 funds tracked by Wall St. Rank hold ACLS as of Q2 2025.

  • Breed's Hill Capital held 3,000 shares of Axcelis worth $209K as of Q2 2025.
  • Axcelis was a new Breed's Hill Capital position in Q2 2025.
  • Axcelis made up 0.1% of Breed's Hill Capital's portfolio in Q2 2025, its #132 holding.
  • Breed's Hill Capital first reported a position in Axcelis in Q4 2024 and has held it in 2 quarters since.
  • Breed's Hill Capital's Axcelis position peaked at $210K in Q4 2024.
  • 328 funds tracked by Wall St. Rank held Axcelis as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.